HK1146229A1 - Wolfberries and inflammation - Google Patents
Wolfberries and inflammationInfo
- Publication number
- HK1146229A1 HK1146229A1 HK11100427.0A HK11100427A HK1146229A1 HK 1146229 A1 HK1146229 A1 HK 1146229A1 HK 11100427 A HK11100427 A HK 11100427A HK 1146229 A1 HK1146229 A1 HK 1146229A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- wolfberries
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07116190A EP2036568A1 (en) | 2007-09-12 | 2007-09-12 | Wolfberries and inflammation |
PCT/EP2008/062122 WO2009034162A1 (en) | 2007-09-12 | 2008-09-12 | Wolfberries and inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1146229A1 true HK1146229A1 (en) | 2011-05-20 |
Family
ID=38984201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11100427.0A HK1146229A1 (en) | 2007-09-12 | 2011-01-17 | Wolfberries and inflammation |
Country Status (16)
Country | Link |
---|---|
US (2) | US9072769B2 (pt) |
EP (3) | EP2036568A1 (pt) |
JP (1) | JP2010540415A (pt) |
CN (2) | CN103417728A (pt) |
AR (1) | AR068448A1 (pt) |
AU (1) | AU2008297074A1 (pt) |
BR (1) | BRPI0816789A2 (pt) |
CA (2) | CA2698860A1 (pt) |
CL (1) | CL2008002692A1 (pt) |
ES (1) | ES2698199T3 (pt) |
HK (1) | HK1146229A1 (pt) |
MX (1) | MX2010002499A (pt) |
PT (1) | PT2200624T (pt) |
RU (1) | RU2499604C2 (pt) |
TW (1) | TW200930389A (pt) |
WO (2) | WO2009034165A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1096344A (en) * | 1964-04-02 | 1967-12-29 | Sandoz Ltd | Improvements in or relating to organic compounds |
TW201021821A (en) * | 2008-12-10 | 2010-06-16 | Fl Dauern Res Inc | Formulations and methods for maintaining normal levels of catecholamines, glucocorticoids, androsteroids and their related hormones |
EP2473180A2 (en) * | 2009-09-02 | 2012-07-11 | Access Business Group International LLC | Composition and method for skin repair |
WO2011079212A2 (en) * | 2009-12-24 | 2011-06-30 | LifeSpan Extension, LLC | Methods and compositions for identifying, producing and using plant-derived products modulating cell function and aging |
MY171851A (en) | 2011-06-20 | 2019-11-04 | Heinz Co Brands H J Llc | Probiotic compositions and methods |
CN103027879A (zh) * | 2011-09-29 | 2013-04-10 | 庞来祥 | 一种具有保湿作用的枸杞唇膏及其制备方法 |
TR201815457T4 (tr) | 2012-04-23 | 2018-11-21 | Univ Oslo | Domates ekstraktının antihipertansif ajan olarak kullanımı ve suda çözünebilen şekersiz domates ekstraktı üretmeye yönelik işlem. |
GB201223365D0 (en) | 2012-12-24 | 2013-02-06 | Provexis Natural Products Ltd | Compositions |
CN105997774A (zh) * | 2016-05-10 | 2016-10-12 | 芜湖亮晶晶生物科技有限公司 | 一种止血消炎牙膏及其制备方法 |
IL266397B (en) | 2016-11-02 | 2022-08-01 | Provexis Natural Products Ltd | Preparations containing water-soluble tomato extract to protect against side effects of air pollution |
CN106667937B (zh) * | 2017-01-03 | 2020-01-17 | 河北省农林科学院经济作物研究所 | 一种黑枸杞多糖咀嚼片 |
TWI727584B (zh) | 2019-06-20 | 2021-05-11 | 財團法人工業技術研究院 | 抑制皮膚細胞增生及/或抗發炎之組成物以及芹菜素與木犀草素在製備抑制皮膚細胞增生及/或抗發炎之組成物的用途 |
CN110742883A (zh) * | 2019-12-05 | 2020-02-04 | 华南农业大学 | 二氢杨梅素在缓解呕吐毒素引起肠道细胞损伤中的应用 |
CN112022767B (zh) * | 2020-09-17 | 2023-04-07 | 云南省药物研究所 | 一种抗炎抑菌增强免疫祛痘组合物及其应用 |
WO2023116621A1 (en) * | 2021-12-20 | 2023-06-29 | Societe Des Produits Nestle S.A. | Process for preparing a berry composition |
CN114209810B (zh) * | 2022-01-06 | 2023-02-07 | 宁夏杞肽科技有限公司 | 枸杞糖肽在制备用于预防或治疗炎性肠病的药物中的用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1100949A (zh) * | 1994-03-11 | 1995-04-05 | 李启才 | 金樱保健系列产品及其制法 |
CN1135338A (zh) * | 1995-05-06 | 1996-11-13 | 孙秀英 | 芸杞保健茶 |
CN1296757A (zh) * | 2000-07-09 | 2001-05-30 | 鄂来明 | 芦荟奶制品 |
WO2003057707A1 (en) * | 2001-12-28 | 2003-07-17 | Suntory Limited | 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
RU2302879C2 (ru) * | 2002-04-09 | 2007-07-20 | Сычуан Институте Оф Чайниз Материа Медика | Фармацевтическая композиция для лечения ревматизма, способ ее приготовления и применение |
TW200515914A (en) * | 2002-11-08 | 2005-05-16 | Wackvom Ltd | Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same |
JPWO2005018656A1 (ja) * | 2003-08-21 | 2006-10-19 | 株式会社カネカ | 脳神経細胞死予防及び/または改善剤 |
US20080254152A1 (en) * | 2003-12-18 | 2008-10-16 | Karen Elizabeth Barrett | Methods for Reducing the Effects of Stress on Skin Condition |
MY142017A (en) * | 2004-03-19 | 2010-08-16 | Nestec Sa | Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same |
US20060024339A1 (en) * | 2004-07-29 | 2006-02-02 | Howard Murad | Methods of managing the redness associated with a dermatological condition |
US7776915B2 (en) * | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
JP2007176814A (ja) | 2005-12-27 | 2007-07-12 | Yoshihiro Futamura | 炎症性サイトカイン産生抑制作用を有するゼアキサンチン誘導体、それからなる食品製剤、化粧品、抗炎症剤 |
-
2007
- 2007-09-12 EP EP07116190A patent/EP2036568A1/en not_active Withdrawn
-
2008
- 2008-09-10 CL CL2008002692A patent/CL2008002692A1/es unknown
- 2008-09-12 US US12/677,488 patent/US9072769B2/en active Active
- 2008-09-12 EP EP08804097.7A patent/EP2200624B1/en active Active
- 2008-09-12 TW TW097135292A patent/TW200930389A/zh unknown
- 2008-09-12 JP JP2010524498A patent/JP2010540415A/ja active Pending
- 2008-09-12 AU AU2008297074A patent/AU2008297074A1/en not_active Abandoned
- 2008-09-12 US US12/677,978 patent/US20100303741A1/en not_active Abandoned
- 2008-09-12 WO PCT/EP2008/062132 patent/WO2009034165A1/en active Application Filing
- 2008-09-12 CN CN2013102855067A patent/CN103417728A/zh active Pending
- 2008-09-12 RU RU2010114192/15A patent/RU2499604C2/ru not_active IP Right Cessation
- 2008-09-12 MX MX2010002499A patent/MX2010002499A/es active IP Right Grant
- 2008-09-12 CN CN2008801060708A patent/CN101795699B/zh not_active Expired - Fee Related
- 2008-09-12 PT PT08804097T patent/PT2200624T/pt unknown
- 2008-09-12 EP EP08804087A patent/EP2200623A1/en not_active Withdrawn
- 2008-09-12 WO PCT/EP2008/062122 patent/WO2009034162A1/en active Application Filing
- 2008-09-12 CA CA2698860A patent/CA2698860A1/en not_active Abandoned
- 2008-09-12 CA CA2699233A patent/CA2699233C/en not_active Expired - Fee Related
- 2008-09-12 BR BRPI0816789 patent/BRPI0816789A2/pt not_active IP Right Cessation
- 2008-09-12 ES ES08804097T patent/ES2698199T3/es active Active
- 2008-09-12 AR ARP080103994A patent/AR068448A1/es not_active Application Discontinuation
-
2011
- 2011-01-17 HK HK11100427.0A patent/HK1146229A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101795699B (zh) | 2013-07-10 |
BRPI0816789A2 (pt) | 2015-03-17 |
RU2499604C2 (ru) | 2013-11-27 |
CA2699233C (en) | 2019-03-19 |
RU2010114192A (ru) | 2011-10-20 |
EP2200624B1 (en) | 2018-09-05 |
CN101795699A (zh) | 2010-08-04 |
AR068448A1 (es) | 2009-11-18 |
ES2698199T3 (es) | 2019-02-01 |
US20100221372A1 (en) | 2010-09-02 |
CA2698860A1 (en) | 2009-03-19 |
CN103417728A (zh) | 2013-12-04 |
EP2036568A1 (en) | 2009-03-18 |
US9072769B2 (en) | 2015-07-07 |
TW200930389A (en) | 2009-07-16 |
CL2008002692A1 (es) | 2009-10-16 |
CA2699233A1 (en) | 2009-03-19 |
JP2010540415A (ja) | 2010-12-24 |
PT2200624T (pt) | 2018-11-29 |
AU2008297074A1 (en) | 2009-03-19 |
US20100303741A1 (en) | 2010-12-02 |
WO2009034165A1 (en) | 2009-03-19 |
EP2200624A1 (en) | 2010-06-30 |
MX2010002499A (es) | 2010-04-27 |
EP2200623A1 (en) | 2010-06-30 |
WO2009034162A1 (en) | 2009-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1146229A1 (en) | Wolfberries and inflammation | |
IL205571A0 (en) | 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin | |
GB0701426D0 (en) | Compounds and their use | |
EP2185692A4 (en) | HCO32 AND HCO27 AND RELATED EXAMPLES | |
TWI561237B (en) | Substituted dihydropyrazolones and their use | |
HK1147912A1 (en) | Anti-inflammatory compounds and uses thereof | |
GB0700580D0 (en) | Use | |
GB0822552D0 (en) | New use | |
GB0705915D0 (en) | New use | |
AU2008265104A8 (en) | Indolin-2-ones and aza-indolin-2-ones | |
GB0712503D0 (en) | Use | |
GB2450608B (en) | New use | |
EP2213675A4 (en) | PYRIDOOXAZEPINE DERIVATIVE AND USE THEREOF | |
MY147277A (en) | Vave and dispenser | |
EP2133326A4 (en) | NEW PSEUDOGLYCOLIPID AND ITS USE | |
EP2170874A4 (en) | NEW COMPOUNDS AND THEIR USE | |
GB0811669D0 (en) | Camera assembly and use thereof | |
GB0718718D0 (en) | Compound and use thereof | |
ZA201000357B (en) | 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands | |
IL205987A0 (en) | Bank1 splice variant, its preparation and use | |
EP2177526A4 (en) | 10A-AZALIDE COMPOUND CROSS-LINKED IN POSITION 10A AND POSITION 12 | |
EP2168951A4 (en) | AZOLYLMETHYLIDENHYDRAZINE DERIVATIVE AND ITS USE | |
GB2446640B (en) | Attenuator | |
GB0701096D0 (en) | Use | |
PL383211A1 (pl) | Nowy związek oraz jego zastosowania |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170912 |